The household economic burden of non-communicable diseases in 18 countries.
cardiovascular disease
diabetes
health economics
health insurance
health systems
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
10
2019
revised:
07
01
2020
accepted:
09
01
2020
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
epublish
Résumé
Non-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the United Nations committed to reducing premature mortality from NCDs, including by reducing the burden of healthcare costs. Since 2014, the Prospective Urban and Rural Epidemiology (PURE) Study has been collecting health expenditure data from households with NCDs in 18 countries. Using data from the PURE Study, we estimated risk of catastrophic health spending and impoverishment among households with at least one person with NCDs (cardiovascular disease, diabetes, kidney disease, cancer and respiratory diseases; n=17 435), with hypertension only (a leading risk factor for NCDs; n=11 831) or with neither (n=22 654) by country income group: high-income countries (Canada and Sweden), upper middle income countries (UMICs: Brazil, Chile, Malaysia, Poland, South Africa and Turkey), lower middle income countries (LMICs: the Philippines, Colombia, India, Iran and the Occupied Palestinian Territory) and low-income countries (LICs: Bangladesh, Pakistan, Zimbabwe and Tanzania) and China. The prevalence of catastrophic spending and impoverishment is highest among households with NCDs in LMICs and China. After adjusting for covariates that might drive health expenditure, the absolute risk of catastrophic spending is higher in households with NCDs compared with no NCDs in LMICs (risk difference=1.71%; 95% CI 0.75 to 2.67), UMICs (0.82%; 95% CI 0.37 to 1.27) and China (7.52%; 95% CI 5.88 to 9.16). A similar pattern is observed in UMICs and China for impoverishment. A high proportion of those with NCDs in LICs, especially women (38.7% compared with 12.6% in men), reported not taking medication due to costs. Our findings show that financial protection from healthcare costs for people with NCDs is inadequate, particularly in LMICs and China. While the burden of NCD care may appear greatest in LMICs and China, the burden in LICs may be masked by care foregone due to costs. The high proportion of women reporting foregone care due to cost may in part explain gender inequality in treatment of NCDs.
Sections du résumé
Background
Non-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the United Nations committed to reducing premature mortality from NCDs, including by reducing the burden of healthcare costs. Since 2014, the Prospective Urban and Rural Epidemiology (PURE) Study has been collecting health expenditure data from households with NCDs in 18 countries.
Methods
Using data from the PURE Study, we estimated risk of catastrophic health spending and impoverishment among households with at least one person with NCDs (cardiovascular disease, diabetes, kidney disease, cancer and respiratory diseases; n=17 435), with hypertension only (a leading risk factor for NCDs; n=11 831) or with neither (n=22 654) by country income group: high-income countries (Canada and Sweden), upper middle income countries (UMICs: Brazil, Chile, Malaysia, Poland, South Africa and Turkey), lower middle income countries (LMICs: the Philippines, Colombia, India, Iran and the Occupied Palestinian Territory) and low-income countries (LICs: Bangladesh, Pakistan, Zimbabwe and Tanzania) and China.
Results
The prevalence of catastrophic spending and impoverishment is highest among households with NCDs in LMICs and China. After adjusting for covariates that might drive health expenditure, the absolute risk of catastrophic spending is higher in households with NCDs compared with no NCDs in LMICs (risk difference=1.71%; 95% CI 0.75 to 2.67), UMICs (0.82%; 95% CI 0.37 to 1.27) and China (7.52%; 95% CI 5.88 to 9.16). A similar pattern is observed in UMICs and China for impoverishment. A high proportion of those with NCDs in LICs, especially women (38.7% compared with 12.6% in men), reported not taking medication due to costs.
Conclusions
Our findings show that financial protection from healthcare costs for people with NCDs is inadequate, particularly in LMICs and China. While the burden of NCD care may appear greatest in LMICs and China, the burden in LICs may be masked by care foregone due to costs. The high proportion of women reporting foregone care due to cost may in part explain gender inequality in treatment of NCDs.
Identifiants
pubmed: 32133191
doi: 10.1136/bmjgh-2019-002040
pii: bmjgh-2019-002040
pmc: PMC7042605
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e002040Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104349/Z/14/Z
Pays : United Kingdom
Organisme : CIHR
Pays : Canada
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eur J Epidemiol. 2015 Mar;30(3):163-88
pubmed: 25527371
Am Heart J. 2009 Jul;158(1):1-7.e1
pubmed: 19540385
J Health Econ. 2016 Mar;46:1-15
pubmed: 26812650
Int J Cardiol. 2016 Aug;217 Suppl:S10-2
pubmed: 27381860
Lancet. 2016 Jan 2;387(10013):61-9
pubmed: 26498706
Stud Fam Plann. 2001 Jun;32(2):130-46
pubmed: 11449862
Health Policy Plan. 2016 Dec;31(10):1384-1390
pubmed: 27315830
Glob Heart. 2017 Dec;12(4):305-313
pubmed: 27773540
PLoS One. 2011;6(6):e20821
pubmed: 21695127
Lancet Public Health. 2017 Sep;2(9):e411-e419
pubmed: 29253412
Lancet. 2011 Oct 1;378(9798):1231-43
pubmed: 21872920
BMC Health Serv Res. 2016 Sep 01;16:457
pubmed: 27582052
Bull World Health Organ. 2007 Apr;85(4):279-88
pubmed: 17546309
BJPsych Open. 2019 Apr 08;5(3):e34
pubmed: 31530317
Lancet Glob Health. 2018 Feb;6(2):e169-e179
pubmed: 29248367
JAMA Netw Open. 2019 Apr 5;2(4):e190411
pubmed: 30951154
Int J Equity Health. 2013 May 30;12:38
pubmed: 23718769
Health Aff (Millwood). 2009 Jul-Aug;28(4):1056-66
pubmed: 19597204
Bull World Health Organ. 2000;78(1):66-74
pubmed: 10686734
Lancet Glob Health. 2018 Mar;6(3):e292-e301
pubmed: 29433667
Emerg Infect Dis. 2004 Nov;10(11):2012-6
pubmed: 15550216
Diabetes Care. 2012 Feb;35(2):319-26
pubmed: 22238276
Health Res Policy Syst. 2013 Aug 16;11:31
pubmed: 23947294
Am Heart J. 2013 Oct;166(4):636-646.e4
pubmed: 24093842
Bull World Health Organ. 2002;80(4):300-3
pubmed: 12075366
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
J Clin Hypertens (Greenwich). 2014 Nov;16(11):773-81
pubmed: 25157607
PLoS Med. 2011 Sep;8(9):e1001087
pubmed: 21909246
J Glob Health. 2018 Dec;8(2):020409
pubmed: 30140435
N Engl J Med. 2014 Aug 14;371(7):601-11
pubmed: 25119606
Int J Womens Health. 2016 Jun 07;8:191-202
pubmed: 27354830
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Health Econ. 2008 Dec;17(12):1393-412
pubmed: 18246595
Lancet. 2003 Jul 12;362(9378):111-7
pubmed: 12867110
Lancet Glob Health. 2017 Mar;5(3):e277-e289
pubmed: 28193397